Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A new RCT found that hearing aids didn't significantly reduce the rate of conversion from mild cognitive impairment (MCI) to dementia — but the trial was underpowered due to a lower-than-expected conversion rate. The silver lining? Hearing aid users were far more likely to show cognitive improvement, with 15.3% reverting to normal cognition vs. just 2.4% in the control group. Researchers say the verdict is "not proven," not "no benefit."
A large randomized clinical trial published in JAMA Neurology set out to answer a pressing question: can hearing aids prevent older adults with mild cognitive impairment (MCI) from developing dementia? The short answer — it's complicated. The trial of over 700 older adults in Shanghai found no statistically significant difference in dementia conversion rates between those who received hearing aids and those who received hearing care education alone.
But here's the catch: the trial was underpowered. Dementia conversion rates were lower than anticipated in both groups (3.09% vs. 4.74%), meaning the study wasn't designed to detect such a small difference. Researchers caution this is a verdict of "not proven," not "no benefit."
The more striking finding came from secondary outcomes — hearing aid users were nearly six times more likely to show cognitive improvement, with 15.3% reverting to a normal cognition score compared to just 2.4% in the control group.
By the Numbers:
Why it matters: Hearing loss is the #1 modifiable risk factor for dementia. While this trial didn't definitively prove hearing aids prevent dementia, the dramatic difference in cognitive improvement rates keeps the door wide open — and underscores the urgency for larger, better-powered studies.
